Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Ordinary Shares Nominal value of NIS 0.0000769 per share
-
Shares outstanding
-
45.5M
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
567K
-
Shares change
-
-1.61M
-
Total reported value, excl. options
-
$413K
-
Value change
-
-$1.18M
-
Put/Call ratio
-
0
-
Number of buys
-
6
-
Number of sells
-
-2
-
Price
-
$0.73
Significant Holders of Entera Bio Ltd. - Ordinary Shares Nominal value of NIS 0.0000769 per share (ENTX) as of Q4 2022
13 filings reported holding ENTX - Entera Bio Ltd. - Ordinary Shares Nominal value of NIS 0.0000769 per share as of Q4 2022.
Entera Bio Ltd. - Ordinary Shares Nominal value of NIS 0.0000769 per share (ENTX) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 567K shares
of 45.5M outstanding shares and own 1.25% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (296K shares), RENAISSANCE TECHNOLOGIES LLC (140K shares), MILLENNIUM MANAGEMENT LLC (46K shares), CITADEL ADVISORS LLC (30.5K shares), GEODE CAPITAL MANAGEMENT, LLC (17.6K shares), HRT FINANCIAL LP (15.2K shares), UBS Group AG (10.4K shares), PNC Financial Services Group, Inc. (10K shares), MORGAN STANLEY (1K shares), and BlackRock Inc. (500 shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.